Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Non-small Cell Lung Cancer Metastatic × Ramucirumab × Clear all

Phase

Status

Terminated 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Stomach Neoplasms 3 Carcinoma, Non-Small-Cell Lung 2 Solid Tumors 1 Sarcoma, Synovial 1 Sarcoma 1 Non-small Cell Lung Cancer Metastatic 1 Neoplasms by Site 1 Neoplasms 1 Mesothelioma, Malignant 1 Gastrointestinal Neoplasms 1 Digestive System Neoplasms 1 Advanced Solid Tumor 1 Adenocarcinoma Gastric 1 Adenocarcinoma 1

Interventions

tusamitamab ravtansine 1 pembrolizumab 1 necitumumab 1 Ramucirumab 1 MLN 8237 1 LY3023414 1 Gemcitabine 1 Erlotinib Hydrochloride 1 Cisplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04394624 2025-06-06

CARMEN-LC04

Sanofi

Phase 2 Terminated

31 enrolled 22 charts

Non-small Cell Lung Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡